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AnalysisScientific Misconduct:
More Cops, More Robbers?Abandoning an earlier pretense that research misconduct is too
rare to matter, the scientific community is trying to figure out
how to minimize and police it. Could broadening the definition
be the key?Last February, in a dimly lit room of the
Vancouver Convention Centre, a group
of researchers and university officials
partook in a frenetic dance. The partici-
pants circled around a green plastic
hoop and used only their little fingers to
suspend the hoop in the air. The instructor
then asked them to slowly lower the hoop
to the ground.
Alas! Amid much screaming and
shouting, the hoop rose remorsefully
toward the ceiling. Why? Each little finger
can exert influence only by pressing
upward. Until the parties actually startOfficials and universities struggle to outwrestletalking to each other and figure out what
is happening, the only place the hoop
can go is up.
This group training exercise is a light-
hearted component of a rapid-fire work-
shop on good research conduct run by
the US Office of Research Integrity (ORI).
The ORI—the largest office of its kind in
the world—licenses misconduct proce-
dures, supervises investigations, and
promotes proper research conduct at
more than 5,000 institutions worldwide
that receive funding from the US Depart-
ment of Health.the potential rise in scientific misconduct.
Cell 14ORI was established in the aftermath
of the infamous ‘‘Baltimore case,’’ when
allegations of misconduct were filed
against a junior staff member in David
Baltimore’s laboratory at the Massachu-
setts Institute of Technology. But, after
the Congressional fireworks that attended
this case faded, research conduct issues
and the ORI itself retreated from public
view.
In the past year, however, there has
been an upsurge in global activity to
address research misconduct. Scientists
and editors are pushing universities and
research agencies to take more responsi-
bility for investigating and punishing
misconduct. Canada has put new proce-
dures in place to do this, and other nations
are under pressure to follow suit.
Drip to Deluge?
Two main factors are likely driving this
upsurge in official activity. One is the
drip-drip-drip of high-profile misconduct
cases. In 2005, Seoul National University
unmasked the fraud by the Korean stem
cell biologist, Hwang Woo-Suk, who had
reported the successful production of
human embryonic stem cells by cloning.
Two years later, the Intergovernmental
Panel on Climate Change erroneously
reported false claims that all Himalayan
glaciers would likely melt by 2035. Then,
in 2010, the contentious research of
Andrew Wakefield—which advocated a
link between autism and the measles,
mumps, and rubella vaccine—was dis-
credited when the UK General Medical
Council convicted him of misconduct
and questioned the content of his papers.
A second factor is the flood of hard
information regarding the frequency of
misconduct. The caseload of the ORI
has approximately doubled over the
last decade, during which time the
total number of retractions in scientific
literature has risen tenfold, reaching
400 last year. The emerging subdisci-
pline of research into research integrity
(RRI) has built up a body of evidence
that ‘‘serious misconduct,’’ generally
classified as ‘‘falsification, fabrication,
and plagiarism (FFP)’’ is more frequent
than these numbers suggest and that
shaded forms of misconduct, such as
redundant publication and the suppres-
sion of negative results, are much more
common again.9, June 22, 2012 ª2012 Elsevier Inc. 1417
Still, the scale of the problem remains
open to dispute. In 2010, ORI was
notified of 288 misconduct allegations,
inquiries, and investigations. It also
opened 28 of its own investigations. ORI
deals only with research supported by
the US Department of Health and Human
Services (e.g., the National Institutes of
Health [NIH]), and other US agencies
probably encounter a similar caseload.
Canada investigates 20 cases per
year, and the UKResearch Integrity Office
(UKRIO) receives 1 inquiry per week
from universities seeking advice, accord-
ing to its director, James Parry.
But what fraction of scientific miscon-
duct cases do these numbers represent?
‘‘It’s tough to know if you’re looking at
the tip of the iceberg or the bottom of
the iceberg,’’ says Mark Frankel, director
of scientific responsibility, human rights,
and law at the American Association for
the Advancement of Science (AAAS).
However, the research in this field, the
best of which relies on self-reporting
questionnaires that researchers post
anonymously, suggests that it is the tip
of the iceberg.
According to a widely quoted 2009
metastudy by Daniele Fanelli of the
University of Edinburgh, 2% of re-
searchers confess to FFP, and as many
as one-third confess to lesser forms of
misconduct (Fanelli, 2009). Fanelli, an
evolutionary biologist who now studies
research conduct, says the work has
been surprisingly well received by other
scientists. ‘‘One of the things that has
made misconduct less of a taboo is the
fact that researchers are studying it, the
same way that they would study anything
else.’’
These trends have shifted the way in
which the issue is perceived by scientists.
‘‘The community’s approach has really
changed,’’ says Frankel. ‘‘They were in
denial for many years: but now, with
twenty or thirty people being found guilty
of misconduct each year, researchers
realize that there is a problem.’’
Minor Misconducts Forecast
Fraud?
Around the world, a small cadre of univer-
sity and government officials is charged
with containing this problem. ORI is the
global leader in this field; with a nine
million dollar budget and a staff of 30, it1418 Cell 149, June 22, 2012 ª2012 Elsevierrequires annual certification from some
5,000 institutions worldwide. It also over-
sees their investigations, taking them on
itself when necessary. But ORI’s staff
has slipped from 50 a decade ago, and it
lacked a full-time director from 2009 until
this January, when David Wright, a histo-
rian of science and former research integ-
rity officer at Michigan State University,
took on the role.
Wright says that there has been a shift
during the past decade for ORI investiga-
tors to be more ‘‘friendly and supportive’’
toward the university integrity officers
whose work they supervise. He says he
wants its staff to work hand in hand with
research institutions to strengthen both
their investigations and their training
programs.
But ORI’s reach is limited to publicly
funded health research; it has no jurisdic-
tion over privately or foundation-funded
research, even when most of this takes
place in the same laboratories as NIH
work. And its regime doesn’t extend
to other public funding agencies, who
work by different rules. The National
Science Foundation, for example, differs
from ORI in that it doesn’t publicly
identify those who it finds guilty of
misconduct.
Most importantly, federal agencies
concern themselves with only the narrow-
est definition of research misconduct:
FFP. That decision was made by the
White House back in 2000, after scientific
organizations successfully fought off
recommendations of an independent
commission, which was headed by Ken
Ryan of Harvard University.
Ryan called for a broader definition of
‘‘misconduct’’ that included suppressing
data and mistreating staff. But research
organizations argued that FFP was
fundamentally distinct from these lesser
offenses.
TheWoo-Suk case, however, appeared
to vindicate Ryan’s approach. Before
Woo-Suk was accused of data fabrica-
tion, it was reported that he had used his
laboratory assistants as sources for diffi-
cult-to-obtain human eggs—a serious
accusation that senior colleagues re-
garded as incidental to his work (Cyra-
noski, 2004). Only later did it emerge
that he was fabricating data, too. His
two main papers were retracted by
Science in 2006 (Kennedy, 2006).Inc.That illustrated Ryan’s basic point: if
you’re crassly exploiting female students,
for example, the government probably
shouldn’t be paying for your work.
The United States has nonetheless
stuck with the more narrow definition:
falsification, fabrication, and plagiarism.
But it is the only major power to do so.
‘‘The US system is the oldest,’’ observes
Nicholas Steneck, a research integrity
specialist at the University of Michigan,
‘‘but I wouldn’t call it the most advanced.
What limits it is that its definition of
misconduct is so narrow, and it is limited
to government-funded research.’’
In March, the US National Academy of
Sciences convened a panel, chaired by
Robert Nerem, a bioengineer at Georgia
Tech, to revise Responsible Science, its
landmark 1992 report on research integ-
rity. The panel will report its findings
in early 2013, and study director Tom
Arrison says it will revisit the definition of
misconduct. ‘‘FFP is pretty directly in our
task,’’ Arrison says.
Canucks Take the Lead
One example for the Academy to consider
is Canada’s new Tri-Agency Framework
on the Responsible Conduct of Research.
The agency is backed by the three main
government funding agencies, and it has
a staff of eight to cover a research system
one-tenth the size of that of the United
States.
The responsibility of the agency is to
oversee all research conducted at institu-
tions that receive public funds. ‘‘We use
a much broader definition than FFP, and
cover the breach of any ethics policy,
and any mishandling of public funds,’’
says Susan Zimmerman, the lawyer who
directs the new secretariat in Ottawa.
Last December, Canada implemented
comprehensive new arrangements to
confront the rise in misconduct cases.
Under the new rules, Zimmerman says,
‘‘institutions have to have their own
research conduct policy to cover all of
their research, regardless of the source
of funding.’’ Canadian researchers who
get public grants have to sign a consent
form that will waive their privacy rights in
the event of a ‘‘serious breach’’ of the
Framework.
‘‘This is an important innovation,’’
Zimmerman says. ‘‘There will be clear
authority to publish names of anyone in
breach of the rules.’’ The new office ex-
pects to handle about 20 investigations
in its first year, Zimmerman says.
Canada’s shiny new system sounds
rather like what the rest of the world would
like but isn’t going to get. At a stormy
meeting in London this past January, for
example, journal editors and senior scien-
tists clashed angrily with university and
British government officials, accusing
the latter group of complacency in their
handling of research misconduct.
This meeting was prompted by the
failure of the University College London
to investigate the Wakefield case (he
was eventually investigated by the
General Medical Council and barred
from practicing medicine). The meeting
‘‘got senior people to confront the issue,
which some of them had not been doing,’’
says Fiona Godlee, editor-in-chief of the
British Medical Journal, which co-orga-
nized it with the Committee on Publication
Ethics (COPE).
The meeting was galvanized by a
strong statement from Michael Rawlins,
chairman of the National Institute of
Health and Clinical Excellence (NICE),
which is the body that determines which
drugs are paid for by Britain’s National
Health Service. He accused the universi-
ties and their funding bodies of compla-
cency.
Afterward, he said that they are still
downplaying the misconduct issue.
‘‘There is a problem, both with fraudulent
data and with the failure to publish nega-
tive results,’’ he claims. ‘‘In the world
where I live, the results of clinical trials
are very important. If there is fraud going
on, people will be harmed. It is ultimately
down to the universities. But either they
don’t think there is a problem, or they
think that to touch it will damage their
reputations. So they want to sweep it
under the carpet.’’
In a consensus statement published
after the meeting, COPE called for far
stronger mechanisms to deal with mis-
conduct, including ‘‘proper and secure
financing’’ for the UKRIO.After the UKDepartment of Health with-
drew financial support, that office is now
surviving on a voluntary fee of £2,500
per year from universities, which only
about half of the UK’s main universities
are paying. There have been ‘‘various
roadblocks’’ to the agency’s effective
operation, which includes a lack of
backing from the UK research councils,
concedes Parry, the UKRIO’s only full-
time staff member.
International Arms Race
Additional problems are raised by stark
variation in how research integrity is
perceived in different cultures. German
courts, for example, have been reluctant
to sanction the idea that a university or
state agency can tell an individual
researcher what to do.
Last August, the FASEB Journal re-
tracted a 2003 paper by the German
neuroscientist Nicolai Savaskan. The
US journal had received a letter from
Savaskan’s university, the Charite
Medical School in Berlin, stating that his
paper contained ‘‘gross flaws.’’ Savaskan
sued the university and won. That partic-
ular verdict was overturned on appeal
in May.
Endocrinologist Volker Ba¨hr, who was
appointed as Germany’s first-ever
research integrity officer at Charite last
summer, says that the legacy of Nazism
has left the courts generally inclined
to place free expression above any
institution’s right to sanction scientists.
‘‘As a consequence, it is often difficult
to rectify scientific misconduct,’’ Ba¨hr
says.
Such international variations are now
being investigated by the InterAcademy
Council (IAC), which represents the
national academies—the self-governing
clubs of very senior scientists that ‘‘speak
for science’’ around the world. The IAC’s
study into ‘‘research integrity and scien-
tific responsibility’’ was prompted, in
part, by the damage that the Himalayan
glacier claim did to the global reputation
of the whole IPCC, says Robbert Dijkgraff,Cell 14a physicist and president of the Royal
Netherlands Academy who also cochairs
the IAC. ‘‘Misconduct by one scientist in
country X can undermine public confi-
dence in country Y,’’ he says. ‘‘The thing
we got worried about is where research
happens in large international collabora-
tions —so that the weakest link deter-
mines the outcome.’’
The IAC panel will report this summer
and hopes that its findings will help
universities, agencies, and governments
around the world to better manage
research misconduct. The organization
also plans to produce sets of training
material by next year. Dijkgraff, who
becomes director of the Institute for
Advanced Studies in Princeton in July,
thinks that better training holds the
key. ‘‘We don’t teach our young people
enough sense of the enormous responsi-
bility that they have, or of the conse-
quences of misconduct,’’ he says.
The Internet, Photoshop, cutthroat
competition, and even internationalism
all lead pessimists to fear that research
misconduct can only increase. At the
same time, parts of the community are
taking the problem seriously and are pro-
actively pushing for more government
action and funding to clamp down hard
on it.
‘‘There’s broad recognition of the
scope of the problem and agreement
that it is underreported. It is being
handled better, by and large,’’ says
Wright. ‘‘But there are also more and
more ways for people who want to cheat
to do so—and lack of funding will induce
more of them to try.’’ The result, the ORI
director notes, is a battle between two
conflicting dynamics that isn’t going to
end anytime soon. ‘‘It’s like an arms
race,’’ he asserts.REFERENCES
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